Alere Inc. Reports Employment Inducement Award Pursuant to NYSE Rule 303A.08

Fri Jan 4, 2013 5:49pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130104:nPnNE37452


WALTHAM, Mass.,  Jan. 4, 2013  /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the
"Company") announced today, pursuant to NYSE Rule 303A.08, that it granted an
employment inducement award to Namal Nawana, the Company's new Chief Operating
Officer, as part of his previously disclosed compensation package. On  December
12, 2012, the Company announced the appointment of Mr. Nawana to serve as its
new COO, effective  December 30, 2012.  

As of  December 30, 2012, Mr. Nawana was granted Restricted Stock Units (RSUs)
in Alere Inc. as follows: 5,000 RSUs to vest 1 year after the grant date, 5,000
RSUs to vest 2 years after the grant date, and 100,000 RSUs to vest 3 years
after the grant date. These RSUs were granted as an employment inducement award
outside of Alere Inc.'s current shareholder approved stock options and incentive
plans pursuant to NYSE Rule 303A.08. For the further details regarding Mr.
Nawana's employment and compensation, please see the Company's Current Report on
Form 8-K filed  December 12, 2012  with the Securities and Exchange Commission. 


About Alere Inc.  
By developing new capabilities in near-patient diagnosis, monitoring and health
management, Alere enables individuals to take charge of improving their health
and quality of life at home.  Alere's global leading products and services, as
well as its new product development efforts, focus on cardiology, infectious
disease, toxicology, diabetes, oncology and women's health. Alere is
headquartered in  Waltham, Massachusetts.  

For additional information on Alere, please visit  www.alere.com

SOURCE  Alere Inc.


Doug Guarino, Director of Corporate Relations, +1-781-647-3900
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.